Study Stopped
This study never initiated.
Does Pulmonary Rehabilitation Improve Breathing of COPD Patients
PR-COPD
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death world-wide. Dyspnea (i.e., sensations of breathlessness) is the hallmark symptom of patients with this disease. Pulmonary rehabilitation programs that incorporate exercise training remain the most effective non-pharmacological method of reducing dyspnea in COPD, however it is not understood how exercise training relieves dyspnea. Accordingly, the purpose of this study is to determine if pulmonary rehabilitation can reduce the disparity between the drive to breathe and the breathing response in patients with COPD and to determine if this reduction is associated with improvements in dyspnea during exercise. The investigators hypothesise pulmonary rehabilitation will reduce dyspnea at a standardized work rate and this reduction will be directly related to an improvement in the breathing response.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2013
CompletedFirst Posted
Study publicly available on registry
March 21, 2013
CompletedStudy Start
First participant enrolled
May 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedJanuary 17, 2018
January 1, 2018
1.6 years
March 11, 2013
January 12, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in neuromechanical uncoupling
The relationship between the neural drive (or effort) to breathe and the corresponding mechanical response of the respiratory system.
Parameters will be measured during the 3 visits, at rest and during exercise. Visits 1 & 2 will be 48 hrs apart and within 2 weeks prior to the 8 week pulmonary rehabilitation (PR). Visit 3 will occur within 2 weeks after the completion of the PR.
Secondary Outcomes (1)
Dyspnea
Parameters will be measured during the 3 visits, at rest and during exercise. Visits 1 & 2 will be 48 hrs apart and within 2 weeks prior to the 8 week pulmonary rehabilitation (PR). Visit 3 will occur within 2 weeks after the completion of the PR.
Study Arms (1)
Pulmonary Rehabilitation
EXPERIMENTAL8 weeks of Pulmonary Rehabilitation
Interventions
8 weeks of Pulmonary Rehabilitation including exercise and COPD related education.
Eligibility Criteria
You may qualify if:
- A physician diagnosis of moderate-to-severe COPD
- Stable clinical COPD status (no history of an acute exacerbation requiring antibiotics or prednisone in the past 4 weeks)
- Post-bronchodilator Forced Expiratory Volume in 1 second (FEV1.0) ≥ 30 - \< 80% predicted and FEV1.0/Forced Vital Capacity ratio \< 0.7
- Body mass index \> 18 or \< 35 kg/m2
- Able to read and understand English
You may not qualify if:
- Concurrent participation in or recent completion (\<6 weeks) of pulmonary rehabilitation
- An ulcer or tumor in their esophagus, or a nasal septum deviation (as reported by the participant)
- Had recent nasopharyngeal surgery
- Have a cardiac pacemaker
- Allergies to latex and sensitivities to local anesthetics
- Uncontrolled hypertension
- Diagnosis of diabetes
- Previous physician diagnosis of cardiovascular disease including: angina, acute coronary syndrome, heart failure, cerebrovascular disease, thromboembolic disease, peripheral vascular disease
- Other chronic lung disease including: asthma, interstitial lung disease, or pulmonary hypertension
- Chronic hepatic disease, chronic renal disease, or other systemic inflammatory disease
- Use of chronic oral steroids
- Dementia or uncontrolled psychiatric illness
- A disease other than COPD that could contribute to dyspnea or exercise limitation
- Contraindications to clinical exercise testing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UBC James Hogg Research Centre, St. Paul's Hospital
Vancouver, British Columbia, V6Z1Y6, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jordan A Guenette, Ph.D.
UBC James Hogg Research Centre/ UBC Dept. Physical Therapy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 11, 2013
First Posted
March 21, 2013
Study Start
May 1, 2018
Primary Completion
December 1, 2019
Study Completion
December 1, 2019
Last Updated
January 17, 2018
Record last verified: 2018-01